[1]
2026. In-silico Prediction of Binding Affinities and Pharmacokinetic Parameters of Indoline-2-one Derivatives as Anticancer HDAC Inhibitors. Al Mustansiriyah Journal of Pharmaceutical Sciences. 26, 1 (Mar. 2026), 80–99. DOI:https://doi.org/10.32947/ajps.v26i1.1367.